Sarcoidosis and Beryllium Toxicity Research
Sarcoidosis and Beryllium Toxicity Research is a research topic within Physiology. Science Explorer counts 19k research works in it since 1950. 9.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the clinical characteristics, diagnosis, management, and genetic susceptibility of sarcoidosis, with a specific emphasis on cardiac, pulmonary, and neurosarcoidosis. It also covers the use of various imaging techniques and therapeutic interventions in the context of sarcoidosis.
- Sarcoidosis
- Cardiac
- Diagnosis
- Management
- Pulmonary
- Neurosarcoidosis
- Granulomatous Inflammation
- Genetic Susceptibility
- Imaging
- Therapy
- Research works
- 19k fractional, since 1950
- In the world top 10%
- 1.8k per year above
- Top-10% rate
- 9.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +36% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Sarcoidosis and Beryllium Toxicity Research research?
By volume, the United States and Japan publish the most (1.1k and 270 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.1k works
- 2 Japan 270 works
- 3 India 239 works
- 4 China 226 works
- 5 United Kingdom 175 works
- 6 France 139 works
- 7 Italy 136 works
- 8 Germany 136 works
- 9 Spain 115 works
- 10 Türkiye 107 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Sarcoidosis and Beryllium Toxicity Research research?
By volume in 2022–2025, Cleveland Clinic publishes the most Sarcoidosis and Beryllium Toxicity Research research, followed by All India Institute of Medical Sciences and Mayo Clinic in Arizona.
By volume, 2022–2025
- 1 Cleveland Clinic United States 23 works
- 2 All India Institute of Medical Sciences India 21 works
- 3 Mayo Clinic in Arizona United States 16 works
- 4 Johns Hopkins University United States 15 works
- 5 Mayo Clinic United States 12 works
- 6 Royal Brompton Hospital United Kingdom 12 works
- 7 Johns Hopkins Medicine United States 11 works
- 8 University of Colorado Denver United States 11 works
- 9 Brigham and Women's Hospital United States 11 works
- 10 Mayo Clinic in Florida United States 11 works
Who are the leading researchers in Sarcoidosis and Beryllium Toxicity Research?
The most-cited researchers publishing on Sarcoidosis and Beryllium Toxicity Research include Leslie T. Cooper.
- 1 Leslie T. Cooper 2.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Sarcoidosis and Beryllium Toxicity Research research done?
The largest centres of Sarcoidosis and Beryllium Toxicity Research research in 2022–2025 are London (United Kingdom), Tokyo (Japan), New York (United States) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Tunis.
Largest cities, 2022–2025
Where it is the local speciality
- TunisTN · 26.6 works11×
Location quotient: how much more of its research is in Sarcoidosis and Beryllium Toxicity Research than the world average.
Where is the best place to study Sarcoidosis and Beryllium Toxicity Research?
Among universities, judged by research, University of Colorado Denver, All India Institute of Medical Sciences and Post Graduate Institute of Medical Education and Research score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Colorado Denver United States | 53.7 | 13.6% | 9.7× | 11 | +93.9% |
| 2 | All India Institute of Medical Sciences India | 50.8 | 6.4% | 9.7× | 21 | -9.7% |
| 3 | Post Graduate Institute of Medical Education and Research India | 41.1 | 11.7% | 8.7× | 10 | +32.6% |
| 4 | Imperial College London United Kingdom | 40.1 | 32.4% | 2.5× | 8 | -35.1% |
| 5 | Istanbul University-Cerrahpaşa Türkiye | 37.8 | 0.3% | 11.6× | 10 | — |
| 6 | Sechenov University Russia | 37.8 | 1.5% | 8.2× | 9 | +134.8% |
| 7 | University of Colorado Anschutz Medical Campus United States | 37.4 | 5.5% | 9.1× | 9 | +63.9% |
| 8 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 31.0 | 10.0% | 2.9× | 10 | +175.7% |
| 9 | Yale University United States | 29.6 | 16.3% | 2.5× | 9 | +93.0% |
| 10 | Johns Hopkins University United States | 29.1 | 6.2% | 4.0× | 15 | -13.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Sarcoidosis and Beryllium Toxicity Research research growing?
Output in 2018–2022 was 36% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Sarcoidosis and Beryllium Toxicity Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.